Accuracy of Intraocular Lens Power in High Myopia
Launched by ASSIUT UNIVERSITY · Jan 7, 2018
Trial Information
Current as of May 17, 2025
Unknown status
Keywords
ClinConnect Summary
High myopia or pathological myopia is associated with elongation of axial length longer than 26 mm or refractive error at least-6 diopter.
High myopia is one of the most prevalent refractive condition globally with a higher risk of other eye conditions Moreover in high myopic eyes the incidence of cataract is significantly higher than in non myopic eyes and the progression is also faster.
Calculation of IOL in high myopic eyes remains a challenge often leading to unexpected postoperative hyperopia the main potential sources of errors in IOL calculation for high myopic eyes include AL meas...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - 1- patients with clear lense extraction or cataract \& high myope with{ AL more than 26 mm.
- • 2-their IOLpower is less than 15 diopter or their refraction before operation is more than -6.
- Exclusion Criteria:
- • 1. Keratoconus patients or those with irregular cornea
- • 2. Patients with post operative complications like posterior capsule injury or vitrous loss.
- • 3. patients who had undergone previous intraocular surgery at anterior segment or posterior segment.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials